KVACW

Quote

Short

News

Articles

Message Board

Keen Vision Acquisition Corporation Warrant (NASDAQ : KVACW ) News

News Releases

KVACW News Releases

July 15, 2025 08:00:00 am

GlobeNewswire

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy

June 24, 2025 08:00:00 am

GlobeNewswire

Medera's Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome

June 13, 2025 08:00:00 am

GlobeNewswire

Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025

May 19, 2025 08:00:00 am

GlobeNewswire

Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress

May 12, 2025 08:00:00 am

GlobeNewswire

Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress

April 01, 2025 08:00:00 am

GlobeNewswire

Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit

March 20, 2025 08:00:00 am

GlobeNewswire

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction

March 11, 2025 09:09:44 am

GlobeNewswire

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

February 10, 2025 08:00:00 am

GlobeNewswire

Medera's Novoheart Expands Human Cardiac Research with CTScreen(TM) Installation at University Medical Center, Utrecht

February 07, 2025 08:00:00 am

GlobeNewswire

Medera, Inc. to Participate in Two Upcoming Investor Conferences

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account